Study suggests new antibody therapy for tick-borne disease - University of California, Riverside

Study suggests new antibody therapy for tick-borne disease  University of California, Riverside

Medical professionals and researchers continue to study these findings closely to understand the broader implications for patient care and public health safety.

Further clinical trials and expert recommendations are expected to be published as health authorities review the collected data.